Li J, Mao S, Yang S, Lou Y, et al. Targeting JMJD6/PPARgamma/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma. Oncogene 2025 Sep 30. doi: 10.1038/s41388-025-03581.
PMID: 41028904